More than two decades of people, patients and perseverance
When BioMarin first opened its doors back in 1997, treatment of rare disease was as rare as the conditions themselves. Determined to make a difference, we went on to develop and introduce eight first or best-in-class therapies for genetic disorders with limited-to-no treatment options.
Learn more about our history and how we got our start with the short film “Finding Tomorrows.”
You can also read more about our legacy with A Rare Breed.
A Rare Breed recounts the first 20 years of BioMarin’s history, the struggles we faced in developing drugs for little known conditions, and how we grew into a global enterprise. It follows the researchers, patients, and executives who played a role in advancing novel ideas and how they overcame scientific, regulatory, and financial challenges to bring first-in-class and best-in-class therapies to children who needed them.
A Rare Breed is now available on Amazon with all proceeds going to patient advocacy groups focused on rare disease.
Look back at the news, announcements and milestones that brought us to where we are today.
Learn More about our company milestones ⌃We take on the biggest challenges in rare disease.
Each drug candidate we pursue is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address.
View Now Our Pipeline ⌃Diversity, Equity & Inclusion
We value diverse perspectives from a broad spectrum of backgrounds, education, personalities, skill sets, experiences, and knowledge.
Learn More about Diversity, Equity & Inclusion at BioMarin ⌃Leadership Team
Our management team represents a dynamic cross section of business, clinical and biotechnical expertise.
Learn More about our leadership team ⌃